The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma - GHRP-2_pituitary

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs021180040

Enrollment

Registered

2019-03-26

Start date

2019-05-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Interventions

administration of GHRP-2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Exclusion criteria

Exclusion criteria: Allergy to GHRP-2

Design outcomes

Primary

Measure	Time frame
Serum TSH, GH and prolactin levels after administration of GHRP-2	—

Contacts

Public ContactShingo Murasawa

Hirosaki University Graduate School of Medicine

murashin@hirosaki-u.ac.jp+81-172-39-5062

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026